Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Targeted next generation sequencing of transcriptomes from human treatment-naïve patient-derived prostate tissues, organoids, and organoid-derived cells (unaffected and tumor counterparts)

ABSTRACT: Targeted next generation sequencing of transcriptomes from human treatment-naïve patient-derived prostate tissues, organoids, and organoid-derived cells (unaffected and tumor counterparts)

PROVIDER: PRJNA626585 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11574500_1.fastq.gz	Fastqsanger.gz
	SRR11574500_2.fastq.gz	Fastqsanger.gz
	SRR11574501_1.fastq.gz	Fastqsanger.gz
	SRR11574501_2.fastq.gz	Fastqsanger.gz
	SRR11574502_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

Bulk RNA-seq of MilliporeSigma 3DGro human patient-derived gastrointestinal organoid lines compared to SCC300 human iPSC-derived colon organoid line

Project description:Transcriptomic profiles of 6 commercially-available human patient-derived gastrointestinal organoid lines were obtained and compared to transcriptomic profile of a commercially available human iPSC-induced colon organoid line. Transcriptomic profile of iPSC-derived human colon organoid line was compared after culture in either Corning growth-factor-reduced Matrigel (Corning 356231) or MilliporeSigma growth-factor-reduced ECMGel (E6909)

2022-03-31 | E-MTAB-11557 | biostudies-arrayexpress

Targeted next generation sequencing of transcriptomes from human treatment-naïve patient-derived prostate tissues, organoids, and organoid-derived cells (unaffected and tumor counterparts)

Project description:Human prostate mRNA profiles of organoids, cells, and tissues were generated by targeted next generation sequencing from three patients using Illumina® TruSeq Stranded mRNA prep kit.

2020-04-21 | GSE148937 | GEO

Patient-derived breast cancer organoid study

Project description:Patient-derived breast cancer organoid study

| PRJNA786254 | ENA

Patient-derived breast cancer organoid study

Project description:Patient-derived breast cancer organoid study

| PRJNA786253 | ENA

Naïve and Primed MSC derived exosomes

Project description:Naïve and Primed MSC derived exosomes

| PRJNA575856 | ENA

Expression data of organoid derived from HSCs

Project description:Expression data of organoid derived from HSCs

| PRJNA496603 | ENA

Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer

Project description:The purpose of this study is to investigate whether chemotherapy guided by patient-derived tumor organoid drug test can improve the outcomes of stage IV colorectal cancer.

| 58056 | ecrin-mdr-crc

RNA-seq of single cholangiocyte-derived organoids reveals high organoid-to-organoid variability

Project description:RNA-seq of single cholangiocyte-derived organoids reveals high organoid-to-organoid variability

| PRJNA847447 | ENA

Mimicking tumor cell heterogeneity of colorectal cancer in a patient-derived organoid-fibroblast model

Project description:Patient derived organoids (PDOs) have been established as a 3D culture model which closely recapitulates the in vivo tumor biology. However, one limitation of this culture model is the lack of tumor microenvironment which has a significant role in tumor progression and drug response. To address this, we established and molecularly characterized a novel 3D co-culture model of colorectal cancer (CRC) based on PDOs and patient matched fibroblasts. Both normal and cancer associated fibroblasts, NFs and CAFs respectively, were able to support organoid growth without addition of niche factors to the media. Additionally, co-cultures showed closer resemblance to primary patient material than organoid mono-cultures as evaluated by histology. Finally, RNA gene expression signatures of tumor cells and fibroblasts isolated from mono- or co-cultures demonstrated that co-cultures support greater cell type heterogeneity. In this proteomics dataset we compared pairs of NFs and CAFs derived from five patients. Collectively, we present a newly established human derived organoid-fibroblast model which, closely recapitulates in vivo tumor heterogeneity and involves the tumor microenvironment.

2023-03-14 | PXD032047 | Pride

Fully human umbilical cord-derived organoid for acute liver failure

Project description:We report a fully human UC-derived organoid system that integrates ECM hydrogel, MSCs and reprogrammed hepatocytes, achieving the treatment of acute hepatic failure in case of extreme failure.To explore the mechanism of our organoid in hepatic failure, we performed single cell RNA sequencing of transplanted organoids as well as the original organoid prior to transplantation, we have demonstrated that MSCs were primarily responsible for inhibiting the secretion of inflammatory-inducing cytokines and promoting the secretion of inflammation-inhibiting cytokines by recruiting immune cells migrating into organoid to triggering immune response.

2021-12-31 | GSE165944 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data